Geltor, founded in 2015, is a cutting-edge biodesign company based in the United States, known for its innovative approach to biotech products. The company focuses on developing animal-free and sustainable proteins that cater to the future of biotechnology, food and beverage, manufacturing, and wellness beauty industries.
Geltor emphasizes not only the ecological benefits of their proteins, but also their unmatched biocompatibility and functionality. The company's dedication to high performance is proven by clinical trials, positioning their products as a leader in sustainability and effectiveness. Their commitment to exploring the potential of biotech innovation makes them a standout in animal-free protein development.
Their most recent funding round was a Convertible Note investment completed on 05 May 2023, with key participation from investors like SOSV and indiebio. This signals solid confidence from the investment community in Geltor's vision and growth trajectory.